Tapewire

OTC · USD

VCNX

VACCINEX, INC.

Export transactions ↓
Tapewire entity
9673
SEC CIK
0001205922
Parsed reports
174

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 27, 2020 Filed Mar 30, 2020 17:20 UTC
FRIEDBERG ALBERTDirector · 10% owner
PurchaseCommon Stock 4,000 $4.18 $16,720.00
Disclosure

SEC source: 0000891839-20-000084 · edgar.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 7,625,601

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
March 26, 2020 Filed Mar 26, 2020 18:08 UTC
FRIEDBERG ALBERTDirector · 10% owner
PurchaseCommon Stock 1,000 $4.44 $4,440.00
Disclosure

SEC source: 0000891839-20-000083 · edgar.xml · nonDerivative · entry 5

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 7,621,601

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
March 24, 2020 Filed Mar 26, 2020 18:08 UTC
FRIEDBERG ALBERTDirector · 10% owner
PurchaseCommon Stock 2,000 $4.40 $8,800.00
Disclosure

SEC source: 0000891839-20-000083 · edgar.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 7,620,601

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
March 20, 2020 Filed Mar 23, 2020 17:24 UTC
FRIEDBERG ALBERTDirector · 10% owner
PurchaseCommon Stock 2,000 $4.31 $8,620.00
Disclosure

SEC source: 0000891839-20-000079 · edgar.xml · nonDerivative · entry 5

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 7,618,601

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
March 19, 2020 Filed Mar 23, 2020 17:24 UTC
FRIEDBERG ALBERTDirector · 10% owner
PurchaseCommon Stock 4,000 $4.15 $16,600.00
Disclosure

SEC source: 0000891839-20-000079 · edgar.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 7,616,601

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
March 17, 2020 Filed Mar 17, 2020 20:05 UTC
FRIEDBERG ALBERTDirector · 10% owner
PurchaseCommon Stock 3,440 $4.00 $13,760.00
Disclosure

SEC source: 0000891839-20-000078 · edgar.xml · nonDerivative · entry 6

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 7,612,601

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
March 16, 2020 Filed Mar 17, 2020 20:05 UTC
FRIEDBERG ALBERTDirector · 10% owner
PurchaseCommon Stock 600 $4.15 $2,490.00
Disclosure

SEC source: 0000891839-20-000078 · edgar.xml · nonDerivative · entry 5

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 7,609,161

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
March 13, 2020 Filed Mar 17, 2020 20:05 UTC
FRIEDBERG ALBERTDirector · 10% owner
PurchaseCommon Stock 3,000 $4.28 $12,840.00
Disclosure

SEC source: 0000891839-20-000078 · edgar.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 7,608,561

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
March 10, 2020 Filed Mar 11, 2020 17:09 UTC
FRIEDBERG ALBERTDirector · 10% owner
PurchaseCommon Stock 4,000 $4.20 $16,800.00
Disclosure

SEC source: 0000891839-20-000075 · edgar.xml · nonDerivative · entry 5

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 7,605,561

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
March 09, 2020 Filed Mar 11, 2020 17:09 UTC
FRIEDBERG ALBERTDirector · 10% owner
PurchaseCommon Stock 231 $4.22 $974.82
Disclosure

SEC source: 0000891839-20-000075 · edgar.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 7,601,561

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
February 25, 2020 Filed Feb 26, 2020 16:24 UTC
Smith Ernest S.SVP, Research & CSO
GrantStock Option (Right to Buy) · Derivative 8,000 $0.00 Strike: $6.07 $0.00
Disclosure

SEC source: 0000891839-20-000052 · edgar.xml · derivative · entry 5

Smith Ernest S. · CIK 0001747769 · SVP, Research & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 8,000 shares

Expires 2030-02-24

F4 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the February 25, 2020 grant date.

Read SEC document
February 25, 2020 Filed Feb 26, 2020 16:25 UTC
Zauderer MauriceDirector · President and CEO · 10% owner
GrantStock Option (Right to Buy) · Derivative 28,400 $0.00 Strike: $6.68 $0.00
Disclosure

SEC source: 0000891839-20-000054 · edgar.xml · derivative · entry 9

Zauderer Maurice · CIK 0001747753 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,400

Underlying: Common Stock · 28,400 shares

Expires 2025-02-24

F5 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the February 25, 2020 grant date.

Read SEC document
February 25, 2020 Filed Feb 26, 2020 16:25 UTC
Leonard John E.SVP, Development
GrantStock Option (Right to Buy) · Derivative 4,000 $0.00 Strike: $6.07 $0.00
Disclosure

SEC source: 0000891839-20-000053 · edgar.xml · derivative · entry 5

Leonard John E. · CIK 0001747997 · SVP, Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Common Stock · 4,000 shares

Expires 2030-02-24

F3 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the February 25, 2020 grant date.

Read SEC document
February 25, 2020 Filed Feb 26, 2020 16:23 UTC
Watkins Raymond E.SVP & Chief Operating Officer
GrantStock Option (Right to Buy) · Derivative 8,000 $0.00 Strike: $6.07 $0.00
Disclosure

SEC source: 0000891839-20-000051 · edgar.xml · derivative · entry 6

Watkins Raymond E. · CIK 0001747774 · SVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 8,000 shares

Expires 2030-02-24

F3 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the February 25, 2020 grant date.

Read SEC document
February 25, 2020 Filed Feb 26, 2020 16:23 UTC
Royer Scott E.Chief Financial Officer
GrantStock Option (Right to Buy) · Derivative 2,000 $0.00 Strike: $6.07 $0.00
Disclosure

SEC source: 0000891839-20-000050 · edgar.xml · derivative · entry 4

Royer Scott E. · CIK 0001747756 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

Underlying: Common Stock · 2,000 shares

Expires 2030-02-24

F3 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the February 25, 2020 grant date.

Read SEC document
January 23, 2020 Filed Jan 27, 2020 16:24 UTC PurchaseCommon Stock 39,292 $5.09 $199,996.28
Disclosure

SEC source: 0000891839-20-000033 · edgar.xml · nonDerivative · entry 1

Frieberg Jacob B. · CIK 0001748346 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,292

Read SEC document
January 23, 2020 Filed Jan 27, 2020 16:25 UTC
FRIEDBERG ALBERTDirector · 10% owner
PurchaseCommon Stock 982,318 $5.09 $4,999,998.62
Disclosure

SEC source: 0000891839-20-000034 · edgar.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 7,601,330

F3 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
January 23, 2020 Filed Jan 27, 2020 16:23 UTC
Zauderer MauriceDirector · President and CEO · 10% owner
PurchaseCommon Stock 98,231 $5.09 $499,995.79
Disclosure

SEC source: 0000891839-20-000032 · edgar.xml · nonDerivative · entry 4

Zauderer Maurice · CIK 0001747753 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Vaccinex (Rochester), L.L.C.

Disclosed balance after: 1,097,753

F2 · ownership.nature: Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
December 31, 2019 Filed Jan 6, 2020 16:33 UTC GrantStock Option (Right to Buy) · Derivative 2,737 $0.00 Strike: $4.85 $0.00
Disclosure

SEC source: 0000891839-20-000017 · edgar.xml · derivative · entry 8

Frieberg Jacob B. · CIK 0001748346 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,737

Underlying: Common Stock · 2,737 shares

Expires 2029-12-28

F7 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the fourth quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable.

Read SEC document
December 31, 2019 Filed Jan 6, 2020 16:34 UTC GrantStock Option (Right to Buy) · Derivative 2,737 $0.00 Strike: $4.85 $0.00
Disclosure

SEC source: 0000891839-20-000018 · edgar.xml · derivative · entry 7

Van Strydonck, Gerald E. · CIK 0001748247 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,737

Underlying: Common Stock · 2,737 shares

Expires 2029-12-28

F3 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the fourth quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable.

Read SEC document
September 30, 2019 Filed Oct 2, 2019 08:40 UTC GrantStock Option (Right to Buy) · Derivative 1,856 $0.00 Strike: $7.17 $0.00
Disclosure

SEC source: 0001209191-19-051418 · doc4.xml · derivative · entry 7

VACCINEX, INC. · CIK 0001205922 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,856

Underlying: Common Stock · 1,856 shares

Expires 2019-09-27

F7 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all of such options are immediately exercisable.

Read SEC document
September 30, 2019 Filed Oct 2, 2019 07:59 UTC GrantStock Option (Right to Buy) · Derivative 1,856 $0.00 Strike: $7.17 $0.00
Disclosure

SEC source: 0001209191-19-051415 · doc4.xml · derivative · entry 6

VACCINEX, INC. · CIK 0001205922 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,856

Underlying: Common Stock · 1,856 shares

Expires 2019-09-27

F3 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all of such options are immediately exercisable.

Read SEC document
September 30, 2019 Filed Oct 4, 2019 10:56 UTC GrantStock Option (Right to Buy) · Derivative 1,856 $0.00 Strike: $7.17 $0.00
Disclosure

SEC source: 0001209191-19-052505 · doc4.xml · derivative · entry 7

Frieberg Jacob B. · CIK 0001748346 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,856

Underlying: Common Stock · 1,856 shares

Expires 2019-09-27

F7 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all of such options are immediately exercisable.

Read SEC document
September 30, 2019 Filed Oct 4, 2019 11:36 UTC Amendment GrantStock Option (Right to Buy) · Derivative 1,856 $0.00 Strike: $7.17 $0.00
Disclosure

SEC source: 0001209191-19-052508 · doc4a.xml · derivative · entry 6

VACCINEX, INC. · CIK 0001205922 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,856

Underlying: Common Stock · 1,856 shares

Expires 2019-09-27

F3 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all of such options are immediately exercisable.

Read SEC document
September 30, 2019 Filed Oct 4, 2019 11:22 UTC Amendment GrantStock Option (Right to Buy) · Derivative 1,856 $0.00 Strike: $7.17 $0.00
Disclosure

SEC source: 0001209191-19-052507 · doc4a.xml · derivative · entry 7

VACCINEX, INC. · CIK 0001205922 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,856

Underlying: Common Stock · 1,856 shares

Expires 2019-09-27

F7 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all of such options are immediately exercisable.

Read SEC document
September 30, 2019 Filed Oct 4, 2019 10:57 UTC GrantStock Option (Right to Buy) · Derivative 1,856 $0.00 Strike: $7.17 $0.00
Disclosure

SEC source: 0001209191-19-052506 · doc4.xml · derivative · entry 6

Van Strydonck, Gerald E. · CIK 0001748247 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,856

Underlying: Common Stock · 1,856 shares

Expires 2019-09-27

F3 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all of such options are immediately exercisable.

Read SEC document
September 30, 2019 Filed Jan 6, 2020 16:30 UTC Amendment GrantStock Option (Right to Buy) · Derivative 1,856 $0.00 Strike: $7.17 $0.00
Disclosure

SEC source: 0000891839-20-000015 · edgar.xml · derivative · entry 1

Frieberg Jacob B. · CIK 0001748346 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,856

Underlying: Common Stock · 1,856 shares

Expires 2029-09-27

F2 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all of such options are immediately exerccisable.

F1 · derivative.expiration_date: The original Form 4 contained an incorrect expiration date for these options. This amendment is being filed to correct the expiration date.

Read SEC document
September 30, 2019 Filed Jan 6, 2020 16:32 UTC Amendment GrantStock Option (Right to Buy) · Derivative 1,856 $0.00 Strike: $7.17 $0.00
Disclosure

SEC source: 0000891839-20-000016 · edgar.xml · derivative · entry 1

Van Strydonck, Gerald E. · CIK 0001748247 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,856

Underlying: Common Stock · 1,856 shares

Expires 2029-09-27

F2 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable.

F1 · derivative.expiration_date: The original Form 4 contained an incorrect expiration date for these options. This amendment is being filed to correct the expiration date.

Read SEC document
July 30, 2019 Filed Jul 31, 2019 16:30 UTC
FRIEDBERG ALBERTDirector · 10% owner
PurchaseCommon Stock 1,838,235 $4.08 $7,499,998.80
Disclosure

SEC source: 0000891839-19-000142 · edgar.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 6,619,012

F3 · balance_after: This Form 4 corrects a prior inadvertent administrative error as to the total beneficial ownership reported.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
July 30, 2019 Filed Jul 31, 2019 16:31 UTC
Zauderer MauriceDirector · President and CEO · 10% owner
PurchaseCommon Stock 183,824 $4.08 $750,001.92
Disclosure

SEC source: 0000891839-19-000143 · edgar.xml · nonDerivative · entry 4

Zauderer Maurice · CIK 0001747753 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Vaccinex (Rochester), L.L.C.

Disclosed balance after: 999,522

F2 · ownership.nature: Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
July 26, 2019 Filed Jul 29, 2019 16:37 UTC
FRIEDBERG ALBERTDirector · 10% owner
PurchaseCommon Stock 1,000 $3.99 $3,990.00
Disclosure

SEC source: 0000891839-19-000134 · edgar.xml · nonDerivative · entry 5

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 4,791,521

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
July 25, 2019 Filed Jul 29, 2019 16:37 UTC
FRIEDBERG ALBERTDirector · 10% owner
PurchaseCommon Stock 52 $3.99 $207.48
Disclosure

SEC source: 0000891839-19-000134 · edgar.xml · nonDerivative · entry 4

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 4,790,521

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
June 30, 2019 Filed Jan 15, 2020 16:20 UTC GrantStock Option (Right to Buy) · Derivative 2,385 $0.00 Strike: $5.52 $0.00
Disclosure

SEC source: 0000891839-20-000029 · edgar.xml · derivative · entry 7

Frieberg Jacob B. · CIK 0001748346 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,385

Underlying: Common Stock · 2,385 shares

Expires 2029-06-29

F7 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the second quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable.

Read SEC document
June 30, 2019 Filed Jan 15, 2020 16:20 UTC GrantStock Option (Right to Buy) · Derivative 2,385 $0.00 Strike: $5.52 $0.00
Disclosure

SEC source: 0000891839-20-000030 · edgar.xml · derivative · entry 6

Van Strydonck, Gerald E. · CIK 0001748247 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,385

Underlying: Common Stock · 2,385 shares

Expires 2029-06-29

F3 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the second quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable.

Read SEC document
May 15, 2019 Filed May 17, 2019 16:40 UTC GrantStock Option (Right to Buy) · Derivative 7,718 $0.00 Strike: $7.78 $0.00
Disclosure

SEC source: 0000891839-19-000069 · edgar.xml · derivative · entry 1

MANIAN BALA S · CIK 0000941871 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,718

Underlying: Common Stock · 7,718 shares

Expires not disclosed

F1 · derivative.expiration_date: This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.

Read SEC document
May 15, 2019 Filed May 17, 2019 16:44 UTC GrantStock Option (Right to Buy) · Derivative 7,718 $0.00 Strike: $7.78 $0.00
Disclosure

SEC source: 0000891839-19-000072 · edgar.xml · derivative · entry 6

Frieberg Jacob B. · CIK 0001748346 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,718

Underlying: Common Stock · 7,718 shares

Expires not disclosed

F6 · derivative.expiration_date: This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.

Read SEC document
May 15, 2019 Filed May 17, 2019 17:49 UTC
Goater JeffDirector
GrantStock Option (Right to Buy) · Derivative 7,718 $0.00 Strike: $7.78 $0.00
Disclosure

SEC source: 0000891839-19-000076 · edgar.xml · derivative · entry 4

Goater Jeff · CIK 0001656435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,718

Underlying: Common Stock · 7,718 shares

Expires not disclosed

F2 · derivative.expiration_date: This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.

Read SEC document
May 15, 2019 Filed May 17, 2019 16:41 UTC GrantStock Option (Right to Buy) · Derivative 7,718 $0.00 Strike: $7.78 $0.00
Disclosure

SEC source: 0000891839-19-000070 · edgar.xml · derivative · entry 5

Van Strydonck, Gerald E. · CIK 0001748247 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,718

Underlying: Common Stock · 7,718 shares

Expires not disclosed

F2 · derivative.expiration_date: This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.

Read SEC document
May 15, 2019 Filed May 17, 2019 16:42 UTC GrantStock Option (Right to Buy) · Derivative 7,718 $0.00 Strike: $7.78 $0.00
Disclosure

SEC source: 0000891839-19-000071 · edgar.xml · derivative · entry 2

Berlin Alejandro M. · CIK 0001747958 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,718

Underlying: Common Stock · 7,718 shares

Expires not disclosed

F2 · derivative.expiration_date: This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.

Read SEC document
May 15, 2019 Filed May 17, 2019 16:37 UTC GrantStock Option (Right to Buy) · Derivative 7,718 $0.00 Strike: $7.78 $0.00
Disclosure

SEC source: 0000891839-19-000068 · edgar.xml · derivative · entry 2

Yanni Barbara · CIK 0001610561 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,718

Underlying: Common Stock · 7,718 shares

Expires not disclosed

F2 · derivative.expiration_date: This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.

Read SEC document
March 31, 2019 Filed Apr 2, 2019 16:28 UTC GrantStock Option (Right to Buy) · Derivative 2,501 $0.00 Strike: $5.26 $0.00
Disclosure

SEC source: 0000891839-19-000057 · edgar.xml · derivative · entry 5

Frieberg Jacob B. · CIK 0001748346 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,501

Underlying: Common Stock · 2,501 shares

Expires 2029-03-30

F6 · shares: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of the $8,750 cash compensation earned in the first quarter of 2019 for service as a member of the Issuer's board of directors. The number of options was calculated in accordance wih the Black-Scholes valuation model and all of such options are immediately exercisable.

F6 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of the $8,750 cash compensation earned in the first quarter of 2019 for service as a member of the Issuer's board of directors. The number of options was calculated in accordance wih the Black-Scholes valuation model and all of such options are immediately exercisable.

F6 · derivative.exercise_date: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of the $8,750 cash compensation earned in the first quarter of 2019 for service as a member of the Issuer's board of directors. The number of options was calculated in accordance wih the Black-Scholes valuation model and all of such options are immediately exercisable.

Read SEC document
March 31, 2019 Filed Apr 2, 2019 16:31 UTC GrantStock Option (Right to Buy) · Derivative 2,501 $0.00 Strike: $5.26 $0.00
Disclosure

SEC source: 0000891839-19-000058 · edgar.xml · derivative · entry 4

Van Strydonck, Gerald E. · CIK 0001748247 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,501

Underlying: Common Stock · 2,501 shares

Expires 2029-03-30

F2 · shares: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of the $8,750 cash compensation earned in the first quarter of 2019 for service as a member of the Issuer's board of directors. The number of options was calculated in accordance wih the Black-Scholes valuation model and all of such options are immediately exercisable.

F2 · price: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of the $8,750 cash compensation earned in the first quarter of 2019 for service as a member of the Issuer's board of directors. The number of options was calculated in accordance wih the Black-Scholes valuation model and all of such options are immediately exercisable.

F2 · derivative.exercise_date: Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of the $8,750 cash compensation earned in the first quarter of 2019 for service as a member of the Issuer's board of directors. The number of options was calculated in accordance wih the Black-Scholes valuation model and all of such options are immediately exercisable.

Read SEC document
March 15, 2019 Filed Mar 18, 2019 17:59 UTC Amendment
FRIEDBERG ALBERTDirector · 10% owner
PurchaseCommon Stock 1,000 $3.96 $3,960.00
Disclosure

SEC source: 0000891839-19-000042 · edgar.xml · nonDerivative · entry 5

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

Vaccinex (Rochester), L.L.C. · CIK 0001747866 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 4,790,469

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
March 15, 2019 Filed Mar 18, 2019 17:28 UTC
FRIEDBERG ALBERTDirector · 10% owner
PurchaseCommon Stock 1,000 $3.96 $3,960.00
Disclosure

SEC source: 0000891839-19-000040 · edgar.xml · nonDerivative · entry 5

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

FCMI Parent Co. · CIK 0001678258 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 4,790,469

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
March 15, 2019 Filed Mar 18, 2019 16:30 UTC
FRIEDBERG ALBERTDirector · 10% owner
PurchaseCommon Stock 1,000 $3.96 $3,960.00
Disclosure

SEC source: 0000891839-19-000038 · edgar.xml · nonDerivative · entry 5

FRIEDBERG ALBERT · CIK 0001268239 · Director · 10% owner

Vaccinex (Rochester), L.L.C. · CIK 0001747866 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCMI Parent Co.

Disclosed balance after: 4,790,469

F3 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by FCMI Parent Co. on January 23, 2019.

F4 · ownership.nature: Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
March 15, 2019 Filed Mar 19, 2019 17:04 UTC
Smith Ernest S.SVP, Research & CSO
GrantStock Option (Right to Buy) · Derivative 8,000 $0.00 Strike: $3.90 $0.00
Disclosure

SEC source: 0000891839-19-000049 · edgar.xml · derivative · entry 4

Smith Ernest S. · CIK 0001747769 · SVP, Research & CSO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 8,000 shares

Expires 2029-03-14

F3 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date.

Read SEC document
March 15, 2019 Filed Mar 19, 2019 17:04 UTC
Zauderer MauriceDirector · President and CEO · 10% owner
GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $4.29 $0.00
Disclosure

SEC source: 0000891839-19-000052 · edgar.xml · derivative · entry 9

Zauderer Maurice · CIK 0001747753 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2024-03-14

F5 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date.

Read SEC document
March 15, 2019 Filed Mar 19, 2019 16:49 UTC
Royer Scott E.Chief Financial Officer
GrantStock Option (Right to Buy) · Derivative 2,000 $0.00 Strike: $3.90 $0.00
Disclosure

SEC source: 0000891839-19-000051 · edgar.xml · derivative · entry 3

Royer Scott E. · CIK 0001747756 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

Underlying: Common Stock · 2,000 shares

Expires 2029-03-14

F2 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date.

Read SEC document
March 15, 2019 Filed Mar 19, 2019 16:49 UTC
Watkins Raymond E.SVP & Chief Operating Officer
GrantStock Option (Right to Buy) · Derivative 8,000 $0.00 Strike: $3.90 $0.00
Disclosure

SEC source: 0000891839-19-000050 · edgar.xml · derivative · entry 5

Watkins Raymond E. · CIK 0001747774 · SVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 8,000 shares

Expires 2029-03-14

F3 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date.

Read SEC document
March 15, 2019 Filed Mar 19, 2019 16:48 UTC
Leonard John E.SVP, Development
GrantStock Option (Right to Buy) · Derivative 4,000 $0.00 Strike: $3.90 $0.00
Disclosure

SEC source: 0000891839-19-000048 · edgar.xml · derivative · entry 4

Leonard John E. · CIK 0001747997 · SVP, Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Common Stock · 4,000 shares

Expires 2029-03-14

F3 · derivative.exercise_date: This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.